PATENT CLAIM ANALYSIS

Application Number: 15901063
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "282000"]

Abstract:
A thermoformed pharmaceutical dosage form having a breaking strength of at least 300 N, said dosage form comprising a pharmacologically active ingredient (A), a free physiologically acceptable acid (B) in an amount of from 0.001 wt.-% to 5.0 wt.-%, based on the total weight of the pharmaceutical dosage form, and a polyalkylene oxide (C) having a weight average molecular weight M w  of at least 200,000 g/mol.

Claim (Index 6):
The pharmaceutical dosage form according to  claim 1 , wherein after storage for 4 weeks at 40\u00b0 C. and 75% rel. humidity, the content of pharmacologically active ingredient (A) amounts to at least 98.0% of its original content before storage.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 88.0
- Lexical Diversity: 1.53846
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14841829', '13223384', '14979888', '14287512', '14719351']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7669442754365893
- 35 USC 102 Novelty (BERT): 0.5342290208065398
- Combined Prediction Score: 0.7436727499735842
- Mean Citation Score: 294.533644
- Max Citation Score: 369.1244
- Similarity Product: 368.6326878341913

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test